Immunic (IMUX) Short Interest Ratio & Short Volume $0.91 +0.02 (+2.58%) As of 03:53 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Immunic Short Interest DataImmunic (IMUX) has a short interest of 2.74 million shares. This marks a 32.37% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.0, indicating that it would take 3.0 days of the average trading volume of 720,772 shares to cover all short positions.Current Short Interest2,740,000 sharesPrevious Short Interest2,070,000 sharesChange Vs. Previous Month+32.37%Dollar Volume Sold Short$2.71 millionShort Interest Ratio3.0 Days to CoverLast Record DateApril 30, 2025Outstanding Shares95,818,000 sharesPercentage of Shares Shorted2.86%Today's Trading Volume309,113 sharesAverage Trading Volume720,772 sharesToday's Volume Vs. Average43% Short Selling Immunic? Sign up to receive the latest short interest report for Immunic and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIMUX Short Interest Over TimeIMUX Days to Cover Over TimeIMUX Percentage of Float Shorted Over Time Immunic Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20252,740,000 shares $2.71 million +32.4%N/A3 $0.99 4/15/20252,070,000 shares $2.05 million +2.5%2.4%2.9 $0.99 3/31/20252,020,000 shares $2.20 million -12.9%2.3%2.4 $1.09 3/15/20252,320,000 shares $2.67 million -3.3%2.7%2.6 $1.15 2/28/20252,400,000 shares $2.86 million -5.9%2.7%2.6 $1.19 2/15/20252,550,000 shares $2.55 million -32.0%2.9%2.7 $1.00 1/31/20253,750,000 shares $3.68 million +6.5%N/A4.1 $0.98 1/15/20253,520,000 shares $3.56 million -37.6%N/A3.1 $1.01 12/31/20245,640,000 shares $5.64 million +14.9%N/A5.8 $1.00 12/15/20244,910,000 shares $5.55 million +17.2%N/A5.6 $1.13 Get the Latest News and Ratings for IMUX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immunic and its competitors with MarketBeat's FREE daily newsletter. 11/30/20244,190,000 shares $5.20 million +10.3%N/A4.7 $1.24 11/15/20243,800,000 shares $4.03 million -15.6%N/A4.7 $1.06 10/31/20244,500,000 shares $5.45 million +29.7%N/A6.4 $1.21 10/15/20243,470,000 shares $5.21 million +29.5%N/A6 $1.50 9/30/20242,680,000 shares $4.42 million +14.0%N/A6.9 $1.65 9/15/20242,350,000 shares $3.57 million +0.9%N/A5.7 $1.52 8/31/20242,330,000 shares $3.52 million -7.5%N/A7.6 $1.51 8/15/20242,520,000 shares $3.40 million -6.3%N/A8.7 $1.35 7/31/20242,690,000 shares $3.85 million -8.8%N/A9.4 $1.43 7/15/20242,950,000 shares $4.01 million -2.0%N/A10.7 $1.36 6/30/20243,010,000 shares $3.34 million +1.7%N/A11.8 $1.11 6/15/20242,960,000 shares $3.52 million -22.1%N/A12.5 $1.19 5/31/20243,800,000 shares $4.71 million +34.8%N/A13.6 $1.24 5/15/20242,820,000 shares $3.65 million No ChangeN/A7.2 $1.30 4/30/20242,820,000 shares $3.55 million -2.1%N/A5.7 $1.26 4/15/20242,880,000 shares $3.77 million -5.0%N/A4.9 $1.31 3/31/20243,030,000 shares $4.00 million +22.7%N/A3.1 $1.32 3/15/20242,470,000 shares $3.24 million +11.3%N/A2.5 $1.31 2/29/20242,220,000 shares $3.25 million -11.9%N/A2.4 $1.47 2/15/20242,520,000 shares $3.38 million -2.7%N/A2.9 $1.34 1/31/20242,590,000 shares $3.08 million -20.6%N/A3.3 $1.19 1/15/20243,260,000 shares $4.17 million +48.2%N/A4.2 $1.28 12/31/20232,200,000 shares $3.30 million -6.4%N/A1.9 $1.50 12/15/20232,350,000 shares $3.53 million -15.2%N/A2.9 $1.50 11/30/20232,770,000 shares $3.30 million -6.4%N/A3.5 $1.19 11/15/20232,960,000 shares $2.96 million -9.5%N/A3.8 $1.00 10/31/20233,270,000 shares $3.47 million -24.7%N/A4.1 $1.06 10/15/20234,340,000 shares $5.25 million +77.9%N/A5.4 $1.21 9/30/20232,440,000 shares $3.59 million -2.4%N/A3 $1.47 9/15/20232,500,000 shares $3.58 million +4.6%N/A2.7 $1.43A grave, grave error. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 8/31/20232,390,000 shares $3.99 million +11.7%N/A2.5 $1.67 8/15/20232,140,000 shares $3.66 million +7.5%N/A2.1 $1.71 7/31/20231,990,000 shares $4.80 million -2.0%N/A1.9 $2.41 7/15/20232,030,000 shares $5.14 million -6.5%N/A1.9 $2.53 6/30/20232,170,000 shares $5.45 million +6.9%N/A2.1 $2.51 6/15/20232,030,000 shares $3.35 million -12.9%N/A1.9 $1.65 5/31/20232,330,000 shares $3.84 million -28.3%N/A2 $1.65 5/15/20233,250,000 shares $5.72 million -11.0%N/A2.6 $1.76 4/30/20233,650,000 shares $6.06 million -14.7%N/A2.8 $1.66 4/15/20234,280,000 shares $6.12 million +3.1%N/A3 $1.43 3/31/20234,150,000 shares $6.18 million -5.7%N/A2.7 $1.49 3/15/20234,400,000 shares $7.22 million -21.7%N/A4.4 $1.64 2/28/20235,620,000 shares $11.13 million +4.9%N/A5.6 $1.98 2/15/20235,360,000 shares $11.36 million -10.2%N/A5.6 $2.12 1/31/20235,970,000 shares $14.33 million -13.9%N/A5.5 $2.40 1/15/20236,930,000 shares $10.67 million -2.0%N/A3.6 $1.54 12/30/20227,070,000 shares $9.90 million -1.7%N/A1.8 $1.40 12/15/20227,190,000 shares $8.63 million +2.1%N/A1.9 $1.20 11/30/20227,040,000 shares $9.43 million +0.7%N/A1.9 $1.34 11/15/20226,990,000 shares $10.35 million -0.9%N/A1.9 $1.48 10/31/20227,050,000 shares $12.48 million +92.6%N/A2.1 $1.77 10/15/20223,660,000 shares $36.71 million +418.7%N/A1.2 $10.03 9/30/2022705,600 shares $2.23 million -20.9%N/A0.8 $3.16 9/15/2022892,200 shares $3.57 million -3.2%N/A5.5 $4.00 8/31/2022921,200 shares $4.10 million -5.3%N/A4.4 $4.45 8/15/2022972,600 shares $5.34 million -7.4%N/A1.4 $5.49 7/31/20221,050,000 shares $3.72 million -9.5%N/A1.4 $3.54 7/15/20221,160,000 shares $4.55 million +3.6%N/A1.5 $3.92 6/30/20221,120,000 shares $3.89 million -41.1%N/A1.5 $3.47 6/15/20221,900,000 shares $6.46 million +22.6%N/A2.5 $3.40 5/31/20221,550,000 shares $9.61 million +25.0%N/A2.2 $6.20 5/15/20221,240,000 shares $7.25 million +8.8%N/A4.9 $5.85 4/30/20221,140,000 shares $7.72 million -20.3%N/A5 $6.77 4/15/20221,430,000 shares $14.89 million -5.3%7.0%5.6 $10.41 3/31/20221,510,000 shares $17.06 million -5.0%7.5%6.3 $11.30 3/15/20221,590,000 shares $16.46 million +17.8%7.9%5.6 $10.35 2/28/20221,350,000 shares $15.73 million -4.3%6.7%4.6 $11.65 2/15/20221,410,000 shares $18.65 million +13.7%7.5%5.4 $13.23 1/31/20221,240,000 shares $14.62 million +6.0%6.6%4.7 $11.79 1/15/20221,170,000 shares $13.86 million -14.0%N/A5.4 $11.85 12/31/20211,360,000 shares $13.02 million +29.5%7.2%6.4 $9.57 12/15/20211,050,000 shares $9.29 million +7.4%5.8%4.9 $8.85 11/30/2021978,000 shares $8.34 million +1.8%5.5%4.8 $8.53 11/15/2021961,100 shares $8.89 million +6.1%5.4%4.7 $9.25 10/29/2021905,500 shares $8.44 million +4.2%5.1%4.6 $9.32 10/15/2021868,700 shares $7.53 million -9.5%4.9%4 $8.67 9/30/2021959,700 shares $8.49 million +3.2%5.4%3.6 $8.85 9/15/2021930,400 shares $8.89 million -3.3%5.3%4.1 $9.55 8/31/2021962,400 shares $9.48 million -32.2%5.4%4.1 $9.85 8/13/20211,420,000 shares $13.43 million -13.4%8.0%6.3 $9.46Trump Predicts Dollar Downfall (Ad)READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... This is what President Trump said: "Our currency is crashing and will soon no longer be the world standard, which will be our greatest defeat, frankly, in 200 years." Why Would He Say This?Claim your free, no-strings-attached 2025 Ultimate Guide to Gold IRAs right now. 7/30/20211,640,000 shares $14.48 million -5.8%10.3%7.3 $8.83 7/15/20211,740,000 shares $16.25 million +12.3%10.9%8.5 $9.34 6/30/20211,550,000 shares $19.00 million +6.9%11.7%10.2 $12.26 6/15/20211,450,000 shares $19.00 million -2.0%11.0%10.9 $13.10 5/28/20211,480,000 shares $19.99 million -0.7%11.2%10.9 $13.51 5/14/20211,490,000 shares $19.52 million +0.7%N/A9.2 $13.10 4/30/20211,480,000 shares $22.82 million +2.1%N/A6.5 $15.42 4/15/20211,450,000 shares $21.05 million +2.1%N/A6.4 $14.52 3/31/20211,420,000 shares $20.80 million +52.4%N/A6.1 $14.65 3/15/2021931,800 shares $15.15 million -28.9%N/A3.5 $16.26 2/26/20211,310,000 shares $20.49 million +45.9%N/A5.1 $15.64 2/12/2021897,700 shares $18.38 million -4.8%N/A3.2 $20.47 1/29/2021942,700 shares $15.76 million +38.6%N/A4.1 $16.72 1/15/2021680,000 shares $12.25 million -27.0%N/A2.8 $18.02 12/31/2020931,700 shares $15.29 million +34.7%N/A3.6 $16.41 12/15/2020691,900 shares $12.97 million -34.1%N/A2.4 $18.75 11/30/20201,050,000 shares $18.43 million +33.7%N/A3 $17.55 11/15/2020785,500 shares $14.85 million +6.8%N/A1.7 $18.90 10/30/2020735,200 shares $12.58 million +4.8%N/A1.5 $17.11 10/15/2020701,800 shares $13.27 million -33.8%N/A1.1 $18.91 9/30/20201,060,000 shares $19.68 million +38.0%N/A1.7 $18.57 9/15/2020768,100 shares $13.76 million +64.1%N/A1.2 $17.92 8/31/2020468,200 shares $7.51 million +79.1%N/A0.8 $16.05 8/14/2020261,400 shares $5.18 million +84.9%N/A0.5 $19.83 7/31/2020141,400 shares $2.43 million -3.4%N/A0.3 $17.20 7/15/2020146,400 shares $1.77 million +10.2%1.8%0.4 $12.11 6/30/2020132,800 shares $1.66 million +129.8%1.9%0.4 $12.49 6/15/202057,800 shares $643,314.00 -11.5%0.9%0.2 $11.13 5/29/202065,300 shares $707,852.00 -55.3%1.1%0.3 $10.84 IMUX Short Interest - Frequently Asked Questions What is Immunic's current short interest? Short interest is the volume of Immunic shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 2,740,000 shares of IMUX short. Learn More on Immunic's current short interest. What is a good short interest ratio for Immunic? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMUX shares currently have a short interest ratio of 3.0. Learn More on Immunic's short interest ratio. Which institutional investors are shorting Immunic? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Immunic: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Immunic's short interest increasing or decreasing? Immunic saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 2,740,000 shares, an increase of 32.4% from the previous total of 2,070,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Immunic's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Immunic: Benitec Biopharma Inc. (1.38%), Mereo BioPharma Group plc (4.79%), Atai Life Sciences (8.95%), Erasca, Inc. (13.33%), Checkpoint Therapeutics, Inc. (5.89%), Alpha Teknova, Inc. (28.06%), Humacyte, Inc. (20.00%), SNDL Inc. (1.43%), Cidara Therapeutics, Inc. (5.61%), Olema Pharmaceuticals, Inc. (7.94%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Immunic stock? Short selling IMUX is an investing strategy that aims to generate trading profit from Immunic as its price is falling. IMUX shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Immunic? A short squeeze for Immunic occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IMUX, which in turn drives the price of the stock up even further. How often is Immunic's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMUX, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies BNTC Short Squeeze MREO Short Squeeze ATAI Short Squeeze ERAS Short Squeeze CKPT Short Squeeze TKNO Short Squeeze HUMA Short Squeeze SNDL Short Squeeze CDTX Short Squeeze OLMA Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IMUX) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
